Clinical Research Directory

Inclusion Criteria: 1. Aged 18 years or older; 2. Reported 2 or more signs and symptoms of respiratory infection during pregnancy, including but not limited to: fever, nasal congestion/discharge, cough, and sore throat and/or a positive SARS-CoV-2 test 3. Deliveries at full term or near term (minimum 34 weeks gestation) in Labor and Delivery (L\&D) facilities at Tulane Lakeside Hospital and Clinic or Ochsner Baptist Medical Center who were pregnant during RSV season. 4. History negative for Human Immunodeficiency Virus (HIV) 5. No use of immunosuppressive medications/therapies. 6. Singleton gestation; 7. Willing to allow for follow up of the child via their medical record from the time of delivery to 4 years of age. 8. Clearly understands the study procedures and visit schedule, alternative treatments, and risks involved with the study, and voluntarily agrees to participate by giving written informed consent. 9. English or Spanish proficiency Exclusion Criteria: 1. Under 18 years of age at the time of consent. 2. Gestational age less than 12.0 weeks at the time of consent. 3. Does not report at least 2 of the following signs and symptoms of respiratory infection during pregnancy, including but not limited to: fever, nasal congestion/discharge, cough, and sore throat. 4. Positive medical history for HIV. 5. Current use of immunosuppressive therapies/drugs. 6. Newborn has been diagnosed with congenital abnormality or chronic disease at birth. 7. Unwilling or unable to provide written informed consent. 8. Mother was not pregnant during the RSV season or no positive SARS-CoV-2 test during pregnancy. 9. Subject is unwilling to allow for follow up of the child via medical records from the time of delivery to 4 years of age; 10. Multiple birth; 11. Lacks English or Spanish proficiency Infants will be excluded from the study in the event of a Serious Adverse Event such as fetal or acute neonatal death (in the delivery room) if the mother does not provide clinical consent for an autopsy.